Principal Investigator
Frances Valdes
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20250526
Clinical Trial Summary
LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647